Skip to content
Homepage
Author:
Subtle Medical, Inc.
Posted Date:
June 10, 2026
Subtle Medical Receives FDA Clearance for SubtleHD™(CT), Expanding AI-Powered Image Enhancement into CT Imaging
Subtle Medical, Inc.
June 10, 2026
Subtle Medical Secures $33 Million in Growth Capital Led by Morgan Stanley Expansion Capital and Appoints Industry Veteran Ohad Arazi as CEO
Subtle Medical, Inc.
June 2, 2026
Subtle Medical Receives FDA Clearance for SubtleHD™(PET), Next-Generation AI-Powered Image Acceleration and Enhancement Software
Subtle Medical, Inc.
May 27, 2026
Subtle Medical to Showcase AI Innovations at NVIDIA GTC 2026
Subtle Medical, Inc.
March 11, 2026
Subtle Medical Advances the Future of AI-Powered Imaging at ECR 2026
Subtle Medical, Inc.
March 3, 2026
